Summary & Overview
HCPCS G6042: Amphetamine or Methamphetamine Testing
HCPCS Level II code G6042 designates laboratory testing for amphetamine or methamphetamine. Nationally, this code matters for clinical toxicology, substance-use screening, and medication monitoring across outpatient and clinical laboratory settings. Proper coding supports accurate billing, compliance with payer policies, and consistent reporting of drug testing services.
Key payers included in the coverage landscape are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, typical sites of service, and clinical context for the test. The publication outlines common billing and documentation considerations, benchmarks for utilization where available, and any notable policy updates affecting laboratory toxicology services.
This report provides clinicians, billing professionals, and policy analysts with clear context for use of G6042, situating the code within clinical workflows for drug screening and laboratory confirmation. Data not available in the input are identified in-line where applicable.
Billing Code Overview
HCPCS Level II code G6042 represents Amphetamine or methamphetamine testing. This service involves laboratory analysis to detect the presence of amphetamine or methamphetamine in a patient specimen.
-
Service type: Drug screening/toxicology testing
-
Typical site of service: Clinical laboratory or outpatient laboratory draw site
Clinical & Coding Specifications
Clinical Context
A typical patient is a 28-year-old adult undergoing urine or serum laboratory testing for controlled substances screening or confirmation in an outpatient toxicology laboratory or hospital clinical laboratory. The specimen is submitted for targeted testing to detect and quantify amphetamine or methamphetamine as part of forensic, occupational, pre-employment, pain management, addiction medicine, or emergency department evaluation. The clinical workflow includes collection of a urine or serum specimen, chain-of-custody documentation when required, initial immunoassay screening (if performed), and confirmatory testing using chromatographic and mass spectrometric methods. The laboratory technician performs specimen preparation and analysis; results are reviewed by a pathologist or laboratory director and reported to the ordering clinician. Modifier TC may be appended when only the technical component is billed by the laboratory facility.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
TC | Technical component | Used when the billing facility or laboratory bills only for the technical component (equipment, supplies, technician) of the test. |
26 |